6k24
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='6k24' size='340' side='right'caption='[[6k24]], [[Resolution|resolution]] 2.10Å' scene=''> | <StructureSection load='6k24' size='340' side='right'caption='[[6k24]], [[Resolution|resolution]] 2.10Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6k24]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K24 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K24 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6k24]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Atcc_14581 Atcc 14581]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K24 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K24 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CV0:MESOPORPHYRIN+IX+CONTAINING+Rh'>CV0</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=WAA:(2S)-2-[[(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]carbonylamino]-3-(1H-indol-3-yl)propanoic+acid'>WAA</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CV0:MESOPORPHYRIN+IX+CONTAINING+Rh'>CV0</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=WAA:(2S)-2-[[(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]carbonylamino]-3-(1H-indol-3-yl)propanoic+acid'>WAA</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">cyp102A1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1404 ATCC 14581])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k24 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k24 OCA], [http://pdbe.org/6k24 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k24 RCSB], [http://www.ebi.ac.uk/pdbsum/6k24 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k24 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k24 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k24 OCA], [http://pdbe.org/6k24 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k24 RCSB], [http://www.ebi.ac.uk/pdbsum/6k24 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k24 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/F2Q7T0_BACME F2Q7T0_BACME]] Functions as a fatty acid monooxygenase.[PIRNR:PIRNR000209] | [[http://www.uniprot.org/uniprot/F2Q7T0_BACME F2Q7T0_BACME]] Functions as a fatty acid monooxygenase.[PIRNR:PIRNR000209] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Despite CYP102A1 (P450BM3) representing one of the most extensively researched metalloenzymes, crystallisation of its haem domain upon modification can be a challenge. Crystal structures are indispensable for the efficient structure-based design of P450BM3 as a biocatalyst. The abietane diterpenoid derivative N-abietoyl-l-tryptophan (AbiATrp) is an outstanding crystallisation accelerator for the wild-type P450BM3 haem domain, with visible crystals forming within 2 hours and diffracting to a near-atomic resolution of 1.22 A. Using these crystals as seeds in a cross-microseeding approach, an assortment of P450BM3 haem domain crystal structures, containing previously uncrystallisable decoy molecules and diverse artificial metalloporphyrins binding various ligand molecules, as well as heavily tagged haem-domain variants, could be determined. Some of the structures reported herein could be used as models of different stages of the P450BM3 catalytic cycle. | ||
| + | |||
| + | Crystals in Minutes: Instant On-Site Microcrystallisation of Various Flavours of the CYP102A1 (P450BM3) Haem Domain.,Stanfield JK, Omura K, Matsumoto A, Kasai C, Sugimoto H, Shiro Y, Watanabe Y, Shoji O Angew Chem Int Ed Engl. 2020 Mar 11. doi: 10.1002/anie.201913407. PMID:32157795<ref>PMID:32157795</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 6k24" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Atcc 14581]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Kasai, C]] | [[Category: Kasai, C]] | ||
Revision as of 10:32, 27 March 2020
Structure of the Rhodium Mesoporphyrin IX-Reconstituted CYP102A1 Haem Domain with N-Abietoyl-L-Tryptophan
| |||||||||||
